Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer. [electronic resource]
Producer: 20020913Description: 1495-500 p. digitalISSN:- 0959-8049
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Diarrhea -- chemically induced
- Dose-Response Relationship, Drug
- Esophageal Neoplasms -- drug therapy
- Female
- Hematologic Diseases -- chemically induced
- Humans
- Infusions, Intravenous
- Male
- Maximum Tolerated Dose
- Middle Aged
- Nervous System Diseases -- chemically induced
- Paclitaxel -- administration & dosage
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.